Regulation of Stress-Activated Kinases in Response to Tacaribe Virus Infection and Its Implications for Viral Replication.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
12 09 2022
Historique:
received: 22 08 2022
revised: 06 09 2022
accepted: 08 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

Arenaviruses include important zoonotic pathogens that cause hemorrhagic fever (e.g., Junín virus; JUNV) as well as other viruses that are closely related but apathogenic (e.g., Tacaribe virus; TCRV). We have found that, while TCRV and JUNV differ in their ability to induce apoptosis in infected cells, due to active inhibition of caspase activation by the JUNV nucleoprotein, both viruses trigger similar upstream pro-apoptotic signaling events, including the activation/phosphorylation of p53. In the case of TCRV, the pro-apoptotic factor Bad is also phosphorylated (leading to its inactivation). These events clearly implicate upstream kinases in regulating the induction of apoptosis. Consistent with this, here we show activation in TCRV-infected cells of the stress-activated protein kinases p38 and JNK, which are known to regulate p53 activation, as well as the downstream kinase MK2 and transcription factor c-Jun. We also observed the early transient activation of Akt, but not Erk. Importantly, the chemical inhibition of Akt, p38, JNK and c-Jun all dramatically reduced viral growth, even though we have shown that inhibition of apoptosis itself does not. This indicates that kinase activation is crucial for viral infection, independent of its downstream role in apoptosis regulation, a finding that has the potential to shed further light on the determinants of arenavirus pathogenesis, as well as to inform future therapeutic approaches.

Identifiants

pubmed: 36146824
pii: v14092018
doi: 10.3390/v14092018
pmc: PMC9505436
pii:
doi:

Substances chimiques

Nucleoproteins 0
Transcription Factors 0
Tumor Suppressor Protein p53 0
Proto-Oncogene Proteins c-akt EC 2.7.11.1
p38 Mitogen-Activated Protein Kinases EC 2.7.11.24
Caspases EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Gen Virol. 2016 Apr;97(4):855-866
pubmed: 26769540
Front Cell Infect Microbiol. 2022 Apr 07;12:798978
pubmed: 35463647
Nat Cell Biol. 2011 Mar;13(3):184-90
pubmed: 21364565
Arch Virol. 2022 Mar;167(3):935-940
pubmed: 35133480
J Immunol. 2004 Mar 1;172(5):2861-9
pubmed: 14978087
Front Biosci (Landmark Ed). 2009 Jan 01;14(11):4214-28
pubmed: 19273346
Arch Virol. 2015 Feb;160(2):469-75
pubmed: 25488290
Viruses. 2018 Apr 17;10(4):
pubmed: 29673133
J Biol Chem. 1999 Oct 22;274(43):31108-13
pubmed: 10521512
Antiviral Res. 2008 Apr;78(1):132-9
pubmed: 18054395
J Virol. 2016 Mar 28;90(8):3810-3818
pubmed: 26865707
Antiviral Res. 2008 Feb;77(2):153-6
pubmed: 17961732
Mol Cell. 1999 Apr;3(4):413-22
pubmed: 10230394
Cell Microbiol. 2012 Jul;14(7):1122-34
pubmed: 22405130
J Virol. 2019 Sep 12;93(19):
pubmed: 31270228
Aging (Albany NY). 2009 May 07;1(5):490-502
pubmed: 20157532
Nat Cell Biol. 1999 Jun;1(2):E33-5
pubmed: 10559890
Eur J Epidemiol. 1988 Jun;4(2):259-74
pubmed: 2841151
Front Cell Infect Microbiol. 2017 Feb 06;7:20
pubmed: 28220142
J Virol. 2015 Jul;89(14):7409-13
pubmed: 25926646
PLoS Pathog. 2020 Oct 12;16(10):e1008948
pubmed: 33045019
Virus Res. 2009 Oct;145(1):166-70
pubmed: 19595723
Cancer Biol Ther. 2004 Feb;3(2):156-61
pubmed: 14764989
Nature. 2007 Mar 1;446(7131):92-6
pubmed: 17287727
Cytokine. 2009 Dec;48(3):161-9
pubmed: 19740675
PLoS Pathog. 2009 May;5(5):e1000455
pubmed: 19478873
Mol Cancer. 2018 Feb 19;17(1):48
pubmed: 29455673
Science. 2000 May 12;288(5468):1053-8
pubmed: 10807576
J Med Chem. 2022 Jan 27;65(2):893-921
pubmed: 33539089
J Med Chem. 2022 Jan 27;65(2):955-982
pubmed: 34081439
Antimicrob Agents Chemother. 2021 Mar 18;65(4):
pubmed: 33468464
Arch Virol. 2018 Aug;163(8):2295-2310
pubmed: 29680923
Vet Microbiol. 2010 Jan 27;140(3-4):213-20
pubmed: 19748747
J Cell Physiol. 2019 Jun;234(6):7718-7724
pubmed: 30515823
J Exp Clin Cancer Res. 2019 Mar 8;38(1):121
pubmed: 30850014
J Virol. 2008 Jan;82(2):938-48
pubmed: 18003730
Am J Physiol Cell Physiol. 2011 Aug;301(2):C272-9
pubmed: 21613612
J Virol. 2020 Mar 31;94(8):
pubmed: 31996435
Microbes Infect. 2018 Feb;20(2):65-80
pubmed: 29081359
Nature. 2001 Mar 1;410(6824):37-40
pubmed: 11242034
Mol Cell. 2000 Jul;6(1):41-51
pubmed: 10949026
PLoS Pathog. 2008 Apr 18;4(4):e1000047
pubmed: 18421377
J Biol Chem. 1999 Dec 3;274(49):34859-67
pubmed: 10574959
Antiviral Res. 1994 Jan;23(1):23-31
pubmed: 8141590
J Virol. 2012 Apr;86(8):4578-85
pubmed: 22345463
Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
pubmed: 21372320
J Virol. 2013 Jan;87(1):224-33
pubmed: 23077297
Am J Trop Med Hyg. 1999 Jan;60(1):85-9
pubmed: 9988328
PLoS One. 2014 Jun 11;9(6):e99610
pubmed: 24918927
Mol Cell. 2001 Mar;7(3):683-94
pubmed: 11463392
J Gen Virol. 2019 Aug;100(8):1200-1201
pubmed: 31192784
J Infect Dis. 1987 Mar;155(3):445-55
pubmed: 3805772
J Virol. 2007 Feb;81(4):1923-33
pubmed: 17151108
J Gen Virol. 2014 Apr;95(Pt 4):799-805
pubmed: 24421112
Glia. 2005 May;50(3):235-46
pubmed: 15739188
J Infect Dis. 1998 Feb;177(2):277-83
pubmed: 9466512
PLoS Negl Trop Dis. 2011 May 10;5(5):e1137
pubmed: 21572983
Antiviral Res. 2003 Jan;57(1-2):89-100
pubmed: 12615305
J Biol Chem. 1967 Jul 10;242(13):3226-33
pubmed: 6027796

Auteurs

Julia Holzerland (J)

Laboratory for Arenavirus Biology, Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, 17493 Greifswald, Germany.

Lucie Fénéant (L)

Laboratory for Arenavirus Biology, Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, 17493 Greifswald, Germany.

Allison Groseth (A)

Laboratory for Arenavirus Biology, Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, 17493 Greifswald, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH